These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6995288)
61. Tissue distribution of CysAP activity and its relationship to blood pressure and water balance. Prieto I; Villarejo AB; Segarra AB; Wangensteen R; Banegas I; de Gasparo M; Vanderheyden P; Zorad S; Vives F; Ramírez-Sánchez M Life Sci; 2015 Aug; 134():73-8. PubMed ID: 26006037 [TBL] [Abstract][Full Text] [Related]
62. Analogs of phosphatidylcholine: alpha-adrenergic antagonists from the renal medulla. Smith KA; Prewitt RL; Byers LW; Muirhead EE Hypertension; 1981; 3(4):460-70. PubMed ID: 6118327 [TBL] [Abstract][Full Text] [Related]
63. Cardiovascular hypertrophy in hypertension. Arthur C. Corcoran Memorial Lecture. Tarazi RC Hypertension; 1986 Jun; 8(6 Pt 2):II187-90. PubMed ID: 3013769 [No Abstract] [Full Text] [Related]
64. [Study of the mechanism of action of a vasodepressor lipid of renal origin and its relation to the antihypertensive function of the kidneys]. Somova LI Patol Fiziol Eksp Ter; 1973; 17(1):17-22. PubMed ID: 4755538 [No Abstract] [Full Text] [Related]
65. [Kidney medulla and hypertension, with special reference to antihypertensive lipids]. Masugi F; Hagiwara T; Kumahara Y Nihon Jinzo Gakkai Shi; 1983 Jul; 25(7):846-7. PubMed ID: 6663856 [No Abstract] [Full Text] [Related]
66. Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR. Castro-Moreno P; Pardo JP; Hernández-Muñoz R; López-Guerrero JJ; Del Valle-Mondragón L; Pastelín-Hernández G; Ibarra-Barajas M; Villalobos-Molina R Auton Autacoid Pharmacol; 2012 Oct; 32(3 Pt 4):61-9. PubMed ID: 22994939 [TBL] [Abstract][Full Text] [Related]
67. Chronic hypotensive effects of verapamil in angiotensin hypertension are steroid independent. Lohmeier TE; Montani JP; Smith MJ; Rushing EL Hypertension; 1989 Mar; 13(3):273-82. PubMed ID: 2921081 [TBL] [Abstract][Full Text] [Related]
68. Mechanisms underlying the antihypertensive functions of the renal medulla. Bergström G; Evans RG Acta Physiol Scand; 2004 Aug; 181(4):475-86. PubMed ID: 15283761 [TBL] [Abstract][Full Text] [Related]
69. [Effects of puerarin on blood pressure, blood lipid and renal structure of cold-induced hypertensive mice]. Pan ZJ; Yan GL; Wang LP; Xu XX; Pan L Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Nov; 27(4):436-8. PubMed ID: 22295519 [No Abstract] [Full Text] [Related]
70. [The effect of benzonal and benzamyl on renal function in dogs with experimental hypertension]. Pashinskiĭ VG Farmakol Toksikol; 1967; 30(1):71-4. PubMed ID: 5594363 [No Abstract] [Full Text] [Related]
71. Chemical renal medullectomy. Effect on urinary prostaglandin E2 and plasma renin in response to variations in sodium intake and in relation to blood pressure. Bing RF; Russell GI; Thurston H; Swales JD; Godfrey N; Lazarus Y; Jackson J Hypertension; 1983; 5(6):951-7. PubMed ID: 6360871 [TBL] [Abstract][Full Text] [Related]
72. Renomedullary deficiency. A contributory factor in the pathogenesis of experimental renal hypertension. Susic D; Sparks JC; Machado EA Experientia; 1976 Mar; 32(3):354-5. PubMed ID: 1253908 [No Abstract] [Full Text] [Related]
73. [The osmoregulating function of the kidney and activity of the loop of Henle in water rats, gerbils and Brattleboro rats]. Natochin IuV; Dlouha H; Lavrova EA; Pechurkina NI; Podsekaeva NI Fiziol Zh SSSR Im I M Sechenova; 1983 May; 69(5):695-700. PubMed ID: 6873378 [TBL] [Abstract][Full Text] [Related]
74. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats. Allcock GH; Venema RC; Pollock DM Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985 [TBL] [Abstract][Full Text] [Related]
75. An alternate road. Muirhead EE Blood Press; 1992 Oct; 1(3):132-4. PubMed ID: 1345044 [No Abstract] [Full Text] [Related]